Abstract: An object of the present invention is to provide safe therapeutic agents for asthma inhibiting the delayed type asthmatic reaction in bronchial asthma and having no side effect. The present invention is a therapeutic agents for asthma containing a compound represented by the under chemical formula or a physiologically acceptable base thereof as an effective ingredient, and the drug containing creatine or a physiologically acceptable base thereof as an effective ingredient.
Type:
Grant
Filed:
June 16, 1998
Date of Patent:
July 25, 2000
Assignees:
Yoshiyuki Uchida, Immuno-Bio Japan Co., Ltd.